Kerry Group PLC
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Edmond Scanlon
- Full Time Employees
- 19,420
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Prince's Street Tralee KY Ireland V92 EH11
- IPO Date
- Oct 1, 1986
- Website
- kerrygroup.com
- Similar Companies
- Business
- Kerry Group plc, headquartered in Tralee, County Kerry, Ireland, and founded in 1972, develops, manufactures and supplies taste, nutrition and ingredient solutions to the global food, beverage, pharmaceutical, biotechnology and pet industries. The company operates principally through its Taste & Nutrition segment, which offers flavours, taste modulation systems such as Tastesense Advanced for sugar reduction; functional ingredients and actives including plant-based proteins, fibres, enzymes and probiotics; savoury and sweet solutions for bakery, snacks, beverages and dairy; beverage ingredients like coffee concentrates, creamers and syrups; foodservice solutions; and pharmaceutical excipients and cell nutrition products; alongside Kerry Dairy Ireland, which produces branded and private label chilled dairy products including cheese, butter and milk for Irish, UK and select international markets. Kerry conducts operations across more than 140 countries spanning Europe, the Americas, Asia-Pacific, the Middle East and Africa, serving food and beverage manufacturers, foodservice providers, pharmaceutical companies and retailers via approximately 25,000 employees worldwide. Recent developments include the divestment of Kerry Dairy Ireland to Kerry Co-Operative Creameries, with the co-op acquiring a 70% stake for €350 million in January 2025 and Kerry retaining 30% until a full handover by 2035 for €150 million; the initiation of a €300 million share buyback programme in June 2025; strategic investments in a new coffee manufacturing facility, enzyme capacity expansion in Ireland, cocoa capabilities in France and a Biotechnology Innovation Centre in Leipzig; and first-half 2025 results showing €3.5 billion revenue, 3% volume growth and EBITDA margin expansion to 16.1%.
Company News
Kerry Group Targets 20%-21% Margins as Biotech Fuels Taste and Nutrition Growth
Kerry Group plc (KRYAY) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Kerry Group plc (KRYAY) Q4 2025 Earnings Call Transcript
Sovereign Metals shares rise after Traxys signs graphite offtake MOU for Kasiya
Kerry Group shares dip on 2025 revenues
Tertiary Minerals results highlight progress with its "exciting grassroots discovery"
Optima Health to buy occupational health group PAM in £100m deal
Kerry Group: Slowly Getting Attractive Again
Artisan Value Fund Q3 2025 Top Contributors And Detractors
Kerry Group plc (KRYAY) Q3 2025 Earnings Call Transcript
Kerry Group: Streamlining The Business After Selling The Dairy Division
Kerry Group: Gaining Momentum In Health And Wellness
Should You Bring The Luck Of The Irish To Your Investmets?
Kerry Group: Expect A Big EPS Increase By 2026